Sign In

Masabi lands €2.9 million from m8 Capital

2 November 2011 16:05
By Tornado Staff

Masabi, a UK developer of mobile phone ticketing technology, has completed a €2.9 million Series B round of funding with its existing shareholder, the mobile technology fund m8 Capital.

Masabi offers mobile ticketing technology for the transport sector. Its applications turn mobile phones into personalized ticket machines which allow people to securely purchase and display tickets on almost any mobile phone, not just smartphones. Once people have bought a ticket, their phone can be easily scanned at the gate or by a train guard. This means travelers can avoid ticket machines and queues.

Masabi works in partnership with transport systems integrators, including and Atos, and is deployed with operators including Virgin Trains, Cross Country Trains, First TransPennine Express, First Hull Trains, Chiltern Railways and others. The latest funding round will support the company’s deployments in the UK. It will also be used for the development of new service features, including NFC technology, and for expansion into new markets, particularly the US.

The company secured its Series A funding round of €1.5 million in September 2010.

Related stories
Purple WiFi pulls in €4.3M for social login and location analytics
Mobile messaging app Jongla receives €3.4 million investment
DelfMEMS gets fresh funds for its RF MEMS switches
Shopgate receives funding for its mobile commerce platform founder Breidenbrücker joins 42matters team


Tech investments
From our Online Data Service
VC-backed companies
From our Radar

Recent Deals

Oct 4€16.0MBiopharmaceuticals
Oct 1€12.5MWireless applications
Oct 1€3.1MBiotechnology
Oct 1€10.0MInternet services
Sep 30€25.0MSoftware development
Sep 29€7.1MComputer hardware
Sep 29€12.0MBiopharmaceuticals

For information on Europe's most extensive database on technology funding click here!


BIO-Europe 2015
November 2 - 4, 2015

November 10 - 11, 2015

Press Releases

Sep 30
BioRegio STERN Management
tübingen-based start-up atriva therapeutics gmbh develops innovativ...

Sep 29
swarm64 as raises up to eur7.1m from alliance venture, target partn...

Sep 29
Cristal Therapeutics (formerly Cristal Delivery)
cristal therapeutics starts clinical phase i trial with nanomedicin...

Sep 28
High-Tech Gründerfonds Management
change the way you think storage – cloudplan closed first financing...

Sep 28
protectimmun teams up with johnson & johnson innovation and imperia...

About usContact usLegal Information
Copyright © 1999-2015
Emerging Technology Research Europe Inc. All rights reserved.